Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1087 | 959 | 1087 | 812 | 1467 | - |
Fund Return | 8.72% | -4.11% | 8.72% | -6.7% | 7.96% | - |
Place in category | 122 | 307 | 122 | 365 | 45 | - |
% in Category | 29 | 72 | 29 | 93 | 11 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Eurose Class I shares E | 2.31B | 3.68 | 3.39 | 2.87 | ||
DNCA Invest Eurose Class AD shares | 2.31B | 2.94 | 2.65 | 2.13 | ||
DNCA Invest Eurose Class A shares | 2.31B | 2.94 | 2.65 | 2.13 | ||
DNCA Invest Europe Growth Class B s | 877.27M | -1.85 | -7.41 | 6.76 | ||
DNCA Invest Europe Growth Class F s | 877.27M | -0.23 | -5.89 | 8.30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Europe Growth Class A s | 877.27M | -1.46 | -7.04 | 7.15 | ||
DNCA Invest Europe Growth Class B s | 877.27M | -1.85 | -7.41 | 6.76 | ||
DNCA Invest Europe Growth Class F s | 877.27M | -0.23 | -5.89 | 8.30 | ||
DNCA Invest Europe Growth Class I s | 877.27M | -0.43 | -6.07 | 8.17 | ||
LU1330191385 | 756.44M | -1.65 | 8.17 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.68 | 603.7 | -0.66% | |
Flutter Entertainment | IE00BWT6H894 | 6.29 | 21,850.0 | +1.82% | |
Bonesupport | SE0009858152 | 6.12 | 343.80 | +1.42% | |
Tryg | DK0060636678 | 5.47 | 146.6 | +0.21% | |
AstraZeneca | GB0009895292 | 4.45 | 11,314.0 | +0.73% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | Strong Buy |
Summary | Strong Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review